These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12224536)

  • 1. On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA.
    Green AR; McGregor IS
    Psychopharmacology (Berl); 2002 Aug; 162(4):448-50. PubMed ID: 12224536
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.
    Durkin S; Prendergast A; Harkin A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1894-901. PubMed ID: 18824064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat.
    Cassel JC; Riegert C; Rutz S; Koenig J; Rothmaier K; Cosquer B; Lazarus C; Birthelmer A; Jeltsch H; Jones BC; Jackisch R
    Neuropsychopharmacology; 2005 Oct; 30(10):1870-82. PubMed ID: 15785779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion.
    Orio L; O'Shea E; Sanchez V; Pradillo JM; Escobedo I; Camarero J; Moro MA; Green AR; Colado MI
    J Neurochem; 2004 Jun; 89(6):1445-53. PubMed ID: 15189347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.
    Callaghan PD; Farrand K; Salem A; Hughes P; Daws LC; Irvine RJ
    Eur J Pharmacol; 2006 Sep; 546(1-3):74-81. PubMed ID: 16925993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
    O'Shea E; Esteban B; Camarero J; Green AR; Colado MI
    Neuropharmacology; 2001; 40(1):65-74. PubMed ID: 11077072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter.
    Troelsen KB; Nielsen EØ; Mirza NR
    Psychopharmacology (Berl); 2005 Oct; 181(4):741-50. PubMed ID: 16032412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of benzylpiperazine derivatives on the acute effects of 3,4-methylenedioxymethamphetamine in rat brain.
    Hashimoto K
    Neurosci Lett; 1993 Apr; 152(1-2):17-20. PubMed ID: 7685864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats.
    Walker QD; Williams CN; Jotwani RP; Waller ST; Francis R; Kuhn CM
    Psychopharmacology (Berl); 2007 Jan; 189(4):435-45. PubMed ID: 17019566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram.
    Piper BJ; Fraiman JB; Owens CB; Ali SF; Meyer JS
    Neuropsychopharmacology; 2008 Apr; 33(5):1192-205. PubMed ID: 17609680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain.
    Bhide NS; Lipton JW; Cunningham JI; Yamamoto BK; Gudelsky GA
    Brain Res; 2009 Aug; 1286():32-41. PubMed ID: 19555677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDMA in adolescent male rats: decreased serotonin in the amygdala and behavioral effects in the elevated plus-maze test.
    Faria R; Magalhães A; Monteiro PR; Gomes-Da-Silva J; Amélia Tavares M; Summavielle T
    Ann N Y Acad Sci; 2006 Aug; 1074():643-9. PubMed ID: 17105959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response.
    Broening HW; Bowyer JF; Slikker W
    J Pharmacol Exp Ther; 1995 Oct; 275(1):325-33. PubMed ID: 7562567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Anxiety-Like Behavior within a Batch of Wistar Rats Are Associated with Differences in Serotonergic Transmission, Enhanced by Acute SRI Administration, and Abolished By Serotonin Depletion.
    Näslund J; Studer E; Pettersson R; Hagsäter M; Nilsson S; Nissbrandt H; Eriksson E
    Int J Neuropsychopharmacol; 2015 Feb; 18(8):. PubMed ID: 25716782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion.
    Andó RD; Adori C; Kirilly E; Molnár E; Kovács GG; Ferrington L; Kelly PA; Bagdy G
    Behav Brain Res; 2010 Mar; 207(2):280-9. PubMed ID: 19840819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion.
    Gurtman CG; Morley KC; Li KM; Hunt GE; McGregor IS
    Eur J Pharmacol; 2002 Jun; 446(1-3):89-96. PubMed ID: 12098589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ; Robinson SE; Rosecrans JA
    Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cortical serotonin in anxiety and locomotor activity in Wistar rats.
    Pum ME; Huston JP; Müller CP
    Behav Neurosci; 2009 Apr; 123(2):449-54. PubMed ID: 19331468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.